BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25542370)

  • 1. Infections Related to Totally Implantable Venous-Access Ports: Long-Term Experience in One Center.
    Ji L; Yang J; Miao J; Shao Q; Cao Y; Li H
    Cell Biochem Biophys; 2015 May; 72(1):235-40. PubMed ID: 25542370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications associated with totally implantable venous access port implantation via the internal jugular vein.
    Tsuruta S; Goto Y; Miyake H; Nagai H; Yoshioka Y; Yuasa N; Takamizawa J
    Support Care Cancer; 2020 Jun; 28(6):2761-2768. PubMed ID: 31724073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the Implantation Technique for Totally Implantable Venous Access Ports (TIVAPs) Influence Long-Term Outcome?
    Biacchi D; Sammartino P; Sibio S; Accarpio F; Cardi M; Sapienza P; De Cesare A; Atta JM; Impagnatiello A; Di Giorgio A
    World J Surg; 2016 Feb; 40(2):284-90. PubMed ID: 26341511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for central venous access port-related infection in Chinese cancer patients.
    Wang TY; Lee KD; Chen PT; Chen MC; Chen YY; Huang CE; Kuan FC; Chen CC; Lu CH
    J Formos Med Assoc; 2015 Nov; 114(11):1055-60. PubMed ID: 26253646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of peripherally inserted central catheters (PICCs) versus totally implantable venous-access ports in pediatric oncology patients, a single center study.
    Zhang H; Li Y; Zhu N; Li Y; Fu J; Liu J
    Sci Rep; 2022 Mar; 12(1):3510. PubMed ID: 35241771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver-Mixed Port Reduces Venous Access Port Related Infection Rate Compared to Non-Silver-mixed Port: A Single-center Retrospective Analysis.
    Suzuki T; Michimoto K; Hasumi J; Kisaki S; Hasegawa Y; Fujimori A; Yoshimatsu L; Ashida H; Ojiri H
    Cardiovasc Intervent Radiol; 2023 Dec; 46(12):1696-1702. PubMed ID: 37902854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Totally implantable venous access ports: frequency of complications and analysis of bacterial contamination after ablation].
    Barbut F; Soukouna S; Lalande V; Garcia ML; Neyme D; de Gramont A; Petit JC
    Pathol Biol (Paris); 2004 Dec; 52(10):566-74. PubMed ID: 15596304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
    Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
    Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central line bundle for prevention of central line-associated bloodstream infection for totally implantable venous access devices (ports) in pediatric cancer patients.
    Devrim İ; Oruç Y; Demirağ B; Kara A; Düzgöl M; Uslu S; Yaşar N; Aydın Köker S; Töret E; Bayram N; Vergin C
    J Vasc Access; 2018 Jul; 19(4):358-365. PubMed ID: 29926785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of bloodstream infection associated with totally implantable venous access ports in cancer patient: a systematic review and meta-analysis.
    Jiang M; Li CL; Pan CQ; Yu L
    Support Care Cancer; 2020 Jan; 28(1):361-372. PubMed ID: 31044308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and prognostic significance of infection of totally implantable vascular access port in solid tumor patients: A prospective cohort study.
    Bailleul A; Fulgencio JP; Vimont S; Mordelet C; Ray B; Lassel L; Lapidus N; Quesnel C; Garnier M
    Infect Dis Now; 2023 Oct; 53(8):104766. PubMed ID: 37543258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factor for infection of totally implantable venous access port.
    Chang TC; Yen MH; Kiu KT
    Langenbecks Arch Surg; 2022 Feb; 407(1):343-351. PubMed ID: 34550464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer.
    Voog E; Campion L; du Rusquec P; Bourgeois H; Domont J; Denis F; Emmanuel E; Dupuis O; Ganem G; Lafont C; Le Du K; Pavluc E; Pointreau Y; Roche S; Juhel-Voog L; Zinger M; Solal-Celigny P
    Support Care Cancer; 2018 Jan; 26(1):81-89. PubMed ID: 28756472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of totally implantable venous-access port-related infections.
    Vidal M; Genillon JP; Forestier E; Trouiller S; Pereira B; Mrozek N; Aumeran C; Lesens O
    Med Mal Infect; 2016 Feb; 46(1):32-8. PubMed ID: 26778362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methods for the microbiological diagnosis of totally implantable venous access port-related infections.
    Kaya E; Tollapi L; Pastore A; Aringhieri G; Maisetta G; Barnini S; Paolicchi A; Batoni G; Esin S
    J Med Microbiol; 2020 Nov; 69(11):1273-1284. PubMed ID: 33064069
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcomes of totally implantable venous access port placement via the axillary vein in patients with head and neck malignancy.
    Hong S; Seo TS; Song MG; Seol HY; Suh SI; Ryoo IS
    J Vasc Access; 2019 Mar; 20(2):134-139. PubMed ID: 29923460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: A systematic review and meta-analysis.
    Jiang M; Li CL; Pan CQ; Cui XW; Dietrich CF
    J Thromb Haemost; 2020 Sep; 18(9):2253-2273. PubMed ID: 32479699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late complications of totally implantable venous access ports in patients with cancer: Risk factors and related nursing strategies.
    Yu XY; Xu JL; Li D; Jiang ZF
    Medicine (Baltimore); 2018 Sep; 97(38):e12427. PubMed ID: 30235721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.